China’s Sinopharm approved by WHO for emergency use

China's Sinopharm approved by WHO for emergency use

China’s Sinopharm approved by WHO for emergency use

The World Health Organisation (WHO) on Friday gave the green light to China’s Sinopharm Covid-19 vaccine for emergency use, approving the vaccine to be rolled out globally. It recommends the vaccine for adults 18 years and older, in a two-dose schedule with a spacing of three to four weeks

The WHO had previously only approved the vaccines made by Pfizer, AstraZeneca, Johnson & Johnson and Moderna. But individual health regulators in various countries – especially poorer ones in Africa, Latin America and Asia – have approved Chinese jabs for emergency use.

The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG). The two jab vaccine is an inactivated vaccine called SARS-CoV-2 Vaccine (Vero Cell). Its easy storage requirements make it highly suitable for low-resource settings, the WHO press release said.

China has approved about five of its Covid-19 vaccines for emergency use and especially using Sinopharm and Sinovac vaccines for both at home and abroad.